Shearman & Sterling represented Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Deutsche Bank Securities, Blackstone Capital Markets, Piper Jaffray, Raymond James, Wells Fargo Securities, William Blair and Evercore ISI as underwriters in connection with a secondary public offering of 27,255,000 shares of common stock of Catalent, Inc. by certain of its stockholders, including 3,555,000 shares sold pursuant to the over-allotment option granted to the underwriters by the Selling Stockholders in connection with the offering, which was exercised in full.

Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

THE TEAM